Institutional investments, especially those disclosed through SEC filings, are closely watched by the market. A passive stake of this size by Deep Track Capital could be interpreted as a strong vote of confidence in Context Therapeutics, potentially influencing other investors' perceptions and possibly leading to a short-term positive impact on CNTX's stock price.